BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 9041745)

  • 1. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
    Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
    Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic reproducibility of Pap testing in two regions of Mexico: the need for quality control mechanisms.
    de Ruíz PA; Lazcano Ponce EC; Duarte Torres R; Ruíz Juárez I; Martínez Cortez I
    Bull Pan Am Health Organ; 1996 Dec; 30(4):330-8. PubMed ID: 9041744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
    Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
    Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of PAPNET--a semiautomated system used in the screening against cervical cancer].
    Hølund B; Ejersbo D; Hjortebjerg A
    Ugeskr Laeger; 1998 Sep; 160(40):5802-6. PubMed ID: 9782761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
    Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
    Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory reliability of the Papanicolaou smear.
    Yobs AR; Swanson RA; Lamotte LC
    Obstet Gynecol; 1985 Feb; 65(2):235-44. PubMed ID: 3969236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
    Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SpinThin, a simple, inexpensive technique for preparation of thin-layer cervical cytology from liquid-based specimens: data on 791 cases.
    Khalbuss WE; Rudomina D; Kauff ND; Chuang L; Melamed MR
    Cancer; 2000 Jun; 90(3):135-42. PubMed ID: 10896326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated screening for quality control using PAPNET: a study of 638 negative Pap smears.
    Keyhani-Rofagha S; Palma T; O'Toole RV
    Diagn Cytopathol; 1996 Jun; 14(4):316-20. PubMed ID: 8725131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; Habbema JD; van den Tweel JG
    Mod Pathol; 1999 Nov; 12(11):995-1000. PubMed ID: 10574595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric analysis of dysplasia in cervical cone biopsy specimens in cases with false-negative cytology.
    Hartman B; Kaplan B; Boone D
    Obstet Gynecol; 1986 Dec; 68(6):832-6. PubMed ID: 3785796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of neural network technology for cervical screening: increase in diagnostic consistency and positive scores.
    Kok MR; Boon ME
    Cancer; 1996 Jul; 78(1):112-7. PubMed ID: 8646706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the screening history of Alberta women with invasive cervical cancer.
    Stuart GC; McGregor SE; Duggan MA; Nation JG
    CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of cervical cytologic dysplasia.
    Jordan SW; Smith NL; Dike LS
    Acta Cytol; 1981; 25(3):237-44. PubMed ID: 6942614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized crossover trial of PAPNET for primary cervical screening.
    Irwig L; Macaskill P; Farnsworth A; Wright RG; McCool J; Barratt A; Simpson JM
    J Clin Epidemiol; 2004 Jan; 57(1):75-81. PubMed ID: 15019013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
    Chacho MS; Mattie ME; Schwartz PE
    Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The PAPNET system in cytological rescreening of cervical smears].
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Minerva Ginecol; 1997 Apr; 49(4):139-45. PubMed ID: 9206764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.